UMES School of Pharmacy's Class of 2018 had the highest first-time pass rate in Maryland
The UMES
School of Pharmacy (SOP) achieved an impressive 96.23% first-time pass rate
among our pharmacy graduates taking the 2018 North American Pharmacy Licensure
Exam (NAPLEX). Compared to the 89.46%
first-time pass rate national average, the UMES was the highest of the three
doctor of pharmacy programs in Maryland and the highest among the seven HBCU
pharmacy programs nationwide.
The NAPLEX
measures the pharmacist candidate’s knowledge of the practice of pharmacy. The NAPLEX is one component of the
pharmacist licensing process used by the states as an assessment of a
candidate’s competence to practice. The UMES SOP is a 3 year condensed doctoral
program in contrast to a 4 year curriculum used in most U.S. pharmacy
schools.
Class of 2018*
The National
Association of Boards of Pharmacy (NABP) earlier this month released first-time
pass rates for the 2018 North American Pharmacist Licensure Examination (NAPLEX).
|
|
Maryland Schools of
Pharmacy |
1st-time Pass Rate
|
|
|
University of Maryland Eastern Shore
|
96.23% |
|
|
Notre
Dame of Maryland University
|
87.76%
|
|
|
University
of Maryland at Baltimore
|
87.05%
|
|
|
|
|
|
|
HBCU Schools of
Pharmacy
|
|
|
|
University of Maryland Eastern Shore
|
96.23%
|
|
|
Texas
Southern University
|
88.57%
|
|
|
Howard
University
|
85.96%
|
|
|
Florida
A&M University
|
75.00%
|
|
|
Xavier
University of Louisiana
|
75.00%
|
|
|
Hampton
University
|
72.75%
|
|
|
Chicago
State University
|
57.75%
|
|
|
|
|
|
2018 National
average
|
89.46%
|
* UMES graduated its first pharmacy class in 2013.
Dr. Patrice Jackson-Ayotunde Wins the Prestigious Richard Bernstein Professorship
Dr. Patrice Jackson-Ayotunde has been selected by an external review committee to serve as the Richard Bernstein Professor for a period of three years. Dr. Jackson-Ayotunde is an Associate Professor with tenure in the School of Pharmacy. Over the past ten years, her research has focused on the field of drug design and synthesis of novel chemical entities as potential agents for the treatment of drug-resistant epilepsy. Her research efforts have led to many peer-reviewed publications, abstracts, invited presentations, and most importantly, a U.S. Patent. She received the patent last year for her work in the area of enaminone derivatives.
Mr. Richard Bernstein established an endowed fund through
the University of Maryland Foundation, Inc. to promote excellence at the
University of Maryland Eastern Shore. The endowment is used to provide
financial support for initiatives that encourage outstanding performance among
students and faculty. One of the initiatives for faculty is the Richard Bernstein
Professorship (RBP). The goal of the RBP is to attract and retain
distinguished members of the faculty.
Congratulations Dr. Jackson-Ayotunde!!